RFK JR student studying vaccines – The magazine said no

The US Secretary of Health and skeptical vaccines called Robert F. Kennedy Junior to a decline in a Danish study that did not find any aluminum connection in vaccines and chronic diseases in children – a rare step for the American General official. Aluminum has been used for about a century to enhance the response of the immune system to some vaccines. But some people claim that the component is linked to high rates of childhood disorders such as autism.

Evan Oanski, a specialist in academic publishing and co -founder of the Foundation for the Foundation for the Media Organization, says public health officials in Kennedy’s position rarely ask to retreat from studies. Through this request, “Minister Kennedy has proven that he wanted to bow scientific literature for his will.”

the study¹ In the question, published in Annals of internal medicine In July, it is one of the largest of its kind, looking at 1.2 million children born over more than two decades in Denmark. The authors reported that no great risk was associated with developing autoimmune disorders, allergies or nervous growth by aluminum vehicles in vaccines.

in Category It was published on experiment news on August 1, Kennedy summoned the study, analysis and results of the study. Since his appointment as head of the US Department of Health and Humanitarian Services, Kennedy has exceeded the regular scientific review operations to change vaccine recommendations and grant them projects on the Al -Mersal Rana vaccines.

Annals of internal medicine He says she stands by study and does not have plans to pull her. “The decline is justified only when serious mistakes are invalidated or that there is documented scientific misconduct, none of them happened here.”

The US Department of Health and Humanitarian Services said that Kennedy’s article spoke about itself, and that the administration had no other comment in response to nature Questions about Kennedy’s request to decline.

It is widely used

Aluminum, in the form of salts, such as potassium aluminum sulfate, was given in vaccines – for diseases ranging from pertish cough to pneumonia – to millions of people around the world, and vaccines have been widely studied for safety safety issues²and³. Gary Grohman, an independent virus in Canberra, says there is no evidence of large side effects caused by a small amount of aluminum in vaccines.

But in 2011, a study⁴ Posted in Inorganic Biochemistry Magazine It is claimed that it shows a causal relationship between the high diagnosis of autism in children and increased exposure to aluminum vaccines. In 2012, the World Health Organization Consultative Committee on the safety of vaccine said that the study and another by the authors were “” “” “”Very defective“Because they used inappropriate study designs, incorrect assumptions and doubtful data.

Since then, Grohmann says that the claim that aluminum in vaccines has caused autism has been exposed “over and over.” “If there is a work mechanism where a specific vaccine causes autism, we will see it in 80, 90, 100 % of the people receiving the vaccine, and we do not do that,” he says. He says that any association between autism and vaccines may be a coincidence in timing. “In other words, vaccines may be given at the age of two, and autism may also start genetically at the age of two.”

Aline Cheng, the epidemic scientist at Monash University in Melbourne, Australia, says the Danish study adds to the evidence that vaccines containing aluminum aluminum are safe.

Kennedy fears

Among Kennedy’s criticism of the Danish study was that the analysis excluded the children who died before the age of two. According to Kennedy, this means that children have been excluded “likely to reveal injuries” associated with aluminum exposure.

Kennedy also criticized the fact that the authors did not compare children who were immunized and unacceptable to determine whether any aluminum exposure causes harm, although they have some data about unjust children.

Anders Hviid, the great author and epidemic specialist at the Statens Serum Institute in Copenhagen, Denmark’s Public Health Agency, says other criticisms that were published on the site of the magazines intertwined with Kennedy’s criticism, says Anders Heafid, the first author and epidemic specialist at the Statins Institute in Copenhagen, the Denmark Public Health Agency. Hviid says that he and his colleagues treated the criticism “one by one.” It also published a refute Kennedy’s article on the news of the trial on August 3.